Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy
Clinical trial NCT05949593 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05949593
- Sponsor
- Belite Bio, Inc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-27
- Primary completion
- 2027-06-30
- Enrollment
- 429
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.